Therapeutics Clinical Review Panel (TCRP) modelling group findings: risk of severe COVID-19 outcomes
A report identifying groups in the population at equivalent risk from severe COVID-19 outcomes to any condition in the highest-risk cohort.
Stay updated with breaking news from Therapeutics Taskforce. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A report identifying groups in the population at equivalent risk from severe COVID-19 outcomes to any condition in the highest-risk cohort.
Find out how to access coronavirus (COVID-19) treatments outside of hospital, including information on free prescriptions and lateral flow tests.
The DHSC-led COVID-19 Antivirals and Therapeutics Taskforce co-ordinates the end-to-end provision of treatments for coronavirus (COVID-19) in the UK so patients get access to safe and effective treatments as soon as possible.
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
New guidance outlines free COVID-19 tests will continue to be available to help protect specific groups once free testing for the general public ends on 1 April